Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture
Journal of the American Chemical Society · 2023
DOI: 10.1021/jacs.2c12963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Guijuan Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Scien…. Hauptthemen laut MEDLINE: Protein Disulfide-Isomerases, Thrombosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, China Postdoctoral Science Foundation, State Key Laboratory of Phytochemistry and Plant Resources in West China.
Abstract (Originalsprache)
Extracellular protein disulfide isomerase (PDI) is a promising target for thrombotic-related diseases. Four potent PDI inhibitors with unprecedented chemical architectures, piericones A-D (1-4), were isolated from Pieris japonica. Their structures were elucidated by spectroscopic data analysis, chemical methods, quantum 13C nuclear magnetic resonance DP4+ and electronic circular dichroism calculations, and single-crystal X-ray diffraction analysis. Piericones A (1) and B (2) were nanomolar noncompetitive PDI inhibitors possessing an unprecedented 3,6,10,15-tetraoxatetracyclo[7.6.0.04,9.01,12]pentadecane motif with nine contiguous stereogenic centers. Their biosynthetic pathways were proposed to include a key intermolecular aldol reaction and an intramolecular 1,2-migration reaction. Piericone A (1) significantly inhibited in vitro platelet aggregation and fibrin formation and in vivo thrombus formation via the inhibition of extracellular PDI without increasing the bleeding risk. The molecular docking and dynamics simulation of 1 and 2 provided a novel structure basis to develop PDI inhibitors as potent antithrombotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, People's Republic of China.
- Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, and The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Prov…
- Department of Natural Sciences, Hawaii Pacific University, Kaneohe, Hawaii 96744, United States.
ORCID-Profile: Jiangeng Huang, F David Horgen, Guangmin Yao
Förderung
- Ministry of Science and Technology of the People's Republic of China
- China Postdoctoral Science Foundation
- State Key Laboratory of Phytochemistry and Plant Resources in West China
- Natural Science Foundation of Hubei Province
- American Society of Hematology
- National Natural Science Foundation of China
- State Key Laboratory of Tea Plant Biology and Utilization
Zitieren
APA
Zheng, G., Lv, K., Wang, H., Huang, L., Feng, Y., Gao, B., Sun, Y., Li, Y., Huang, J., Jin, P., Xu, X., Horgen, F. D., Fang, C., & Yao, G. (2023). Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.2c12963
Vancouver
Zheng G, Lv K, Wang H, Huang L, Feng Y, Gao B, et al. Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.2c12963
BibTeX
@article{Zheng2023,
author = {Zheng, Guijuan and Lv, Keyu and Wang, Hao and Huang, Lang and Feng, Yuanyuan and Gao, Biao and Sun, Yenan and Li, Yaofeng and Huang, Jiangeng and Jin, Pengfei and Xu, Xulin and Horgen, F David and Fang, Chao and Yao, Guangmin},
title = {Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture},
journal = {Journal of the American Chemical Society},
year = {2023},
doi = {10.1021/jacs.2c12963}
}
EUVIMED